Literature DB >> 16079297

Chronopharmacological study of antidepressants in forced swimming test of mice.

Kentarou Ushijima1, Hiromi Sakaguchi, Yuki Sato, Hideto To, Satoru Koyanagi, Shun Higuchi, Shigehiro Ohdo.   

Abstract

The influence of dosing time on the anti-immobility effect of antidepressants and mechanisms underlying this phenomenon were investigated in mice. In the forced swimming test (FST), the immobility time of mice treated with amitriptyline (15 mg/kg) and fluvoxamine (30 mg/kg) showed a significant 24-h rhythm. The anti-immobility effect of fluvoxamine in FST was potent at the early part of the dark phase without increasing locomotor activity. Concerning pharmacokinetics, although K(e) of fluvoxamine was approximately 1.3-fold higher in mice injected with fluvoxamine at 9:00 PM than at 9:00 AM, no dosing time dependence was demonstrated for either plasma or brain fluvoxamine concentration at 0.5 h after the drug injection. On the other hand, serotonin transporter (SERT) mRNA expression and 5-hydroxytryptamine (5-HT) uptake activity in the mouse midbrain showed significant time-dependent changes with higher levels during the dark phase and lower levels during the light phase. These results suggest that the reuptake of 5-HT might be more increased during the dark phase. Since the reuptake of 5-HT is inhibited almost completely by injection with 30 mg/kg fluvoxamine at any time, the extracellular 5-HT level may be more increased by the injection of fluvoxamine at the early part of the dark phase. The present results suggest that the anti-immobility effect of fluvoxamine in FST increases depending on dosing time. Furthermore, the time-dependent change of SERT mRNA expression and uptake activity in the midbrain is suggested to be the mechanism underlying the 24-h rhythm of anti-immobility effect of fluvoxamine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079297     DOI: 10.1124/jpet.105.088849

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Intranasal administration of nerve growth factor produces antidepressant-like effects in animals.

Authors:  Cui-ge Shi; Lu-ming Wang; Ying Wu; Peng Wang; Zhu-jun Gan; Kai Lin; Li-xin Jiang; Zhi-qing Xu; Ming Fan
Journal:  Neurochem Res       Date:  2010-06-03       Impact factor: 3.996

Review 2.  Factors influencing behavior in the forced swim test.

Authors:  Olena V Bogdanova; Shami Kanekar; Kristen E D'Anci; Perry F Renshaw
Journal:  Physiol Behav       Date:  2013-05-14

3.  Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts.

Authors:  Kazumi Nomura; Oscar Castanon-Cervantes; Alec Davidson; Chiaki Fukuhara
Journal:  Life Sci       Date:  2008-04-16       Impact factor: 5.037

4.  Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice.

Authors:  Katarzyna Socała; Dorota Nieoczym; Elżbieta Wyska; Ewa Poleszak; Piotr Wlaź
Journal:  J Neural Transm (Vienna)       Date:  2012-01-04       Impact factor: 3.575

5.  Chronopharmacodynamics and chronopharmacokinetics of pethidine in mice.

Authors:  Chengliang Zhang; Zaoqin Yu; Xiping Li; Yanjiao Xu; Dong Liu
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

6.  Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.

Authors:  Keiichiro Hayashi; Hiroyuki Michiue; Hiroshi Yamada; Katsuyoshi Takata; Hiroki Nakayama; Fan-Yan Wei; Atsushi Fujimura; Hiroshi Tazawa; Akira Asai; Naohisa Ogo; Hiroyuki Miyachi; Tei-ichi Nishiki; Kazuhito Tomizawa; Kohji Takei; Hideki Matsui
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

7.  Stress Models of Depression: A Question of Bad Timing.

Authors:  Sarah Delcourte; Ouria Dkhissi-Benyahya; Howard Cooper; Nasser Haddjeri
Journal:  eNeuro       Date:  2017-04-20

8.  Time of Administration of Acute or Chronic Doses of Imipramine Affects its Antidepressant Action in Rats.

Authors:  Hiroshi Kawai; Natsumi Kodaira; Chika Tanaka; Takuya Ishibashi; Naomi Kudo; Yoichi Kawashima; Atsushi Mitsumoto
Journal:  J Circadian Rhythms       Date:  2018-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.